Desonide (Desowen)

Subscribe to Selected New Research on Desonide

31 relevant articles (8 outcomes, 9 trials/studies) found for this Drug

Description: A nonfluorinated corticosteroid anti-inflammatory agent used topically for DERMATOSES.

Also Known As:

Desowen; Tridesilon; Alcon Brand of Desonide; Bayer Brand of Desonide; CS Brand of Desonide; Clay-Park Brand of Desonide; Desocort; Desone; Galderma Brand of Desonide; Locapred; Locatop; Owen Brand of Desonide; Pierre Fabre Brand of Desonide; Tridésonit; Clay Park Brand of Desonide; Prednacinolone; Pregna-1,4-diene-3,20-dione, 11,21-dihydroxy-16,17-((1-methylethylidene)bis(oxy))-, (11beta,16alpha)-

Relationship Network

Drug Context: Research Results

Polycyclic Compounds: 58

Experts

1.	Calvarese, Barry: 2 articles (05/2007 - 02/2007)
2.	Basu, Sarmistha: 2 articles (05/2007 - 02/2007)
3.	Trancik, Ronald J: 2 articles (05/2007 - 02/2007)
4.	Eichenfield, Lawrence F: 1 article (05/2007)
5.	Desonide Hydrogel Study Group: 1 article (02/2007)
6.	Cook-Bolden, Fran E: 1 article (02/2007)
7.	Hebert, Adelaide A: 1 article (02/2007)
8.	Bhankharia, Dimple A: 1 article (09/2004)
9.	Sanjana, Percy H: 1 article (09/2004)
10.	Howard, Anne: 1 article (08/2002)

Related Diseases

1.	Atopic Dermatitis (Atopic Eczema) 08/01/2008 - "METHODS: A phase II open-label study of the effect of desonide foam 0.05% on the hypothalamic-pituitary-adrenal axis was evaluated in pediatric and adolescent participants with mild-to-moderate atopic dermatitis" 08/01/2002 - "The aim of this study was to evaluate a mild- to mid-potent topical corticosteroid, desonide 0.05%, on these three parameters in an Australian cohort of patients with facial seborrhoeic or atopic dermatitis" 03/01/1997 - "Effect of desonide ointment, 0.05%, on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis." 06/01/2000 - "PATIENTS AND METHODS: A randomized double-blind trial was conducted to assess the efficacy of micronized desonide cream 0.1 p.100 (group 1) versus bethamethasone cream dipropionate 0.05 p.100 (group 2) in children treated for atopic dermatitis and to compare their effects on serum cortisol levels 8 hours after administration" 02/01/2007 - "Safety and efficacy of desonide hydrogel 0.05% in pediatric subjects with atopic dermatitis." Get all the results and reference details, order at left...
2.	Skin Diseases 07/01/2004 - "Desonide (as a cream, ointment, or lotion formulation) is widely used for the treatment of steroid-responsive dermatoses" 09/01/2004 - "CONCLUSIONS: Desonide 0.05% is a safe and effective low-potency corticosteroid for the treatment of mild to moderate dermatoses in Indian patients" 09/01/2004 - "Efficacy of desonide 0.05% cream and lotion in steroid-responsive dermatoses in Indian patients: a post-marketing surveillance study." 07/01/2008 - "BACKGROUND: Desonide is a low-potency topical corticosteroid that has been used for decades in the treatment of steroid-responsive dermatoses" 05/01/2007 - "Desonide, a low potency corticosteroid, has been used widely as a topical treatment for inflammatory dermatoses for over 30 years" Get all the results and reference details, order at left...
3.	Hypersensitivity (Allergy) 07/01/2002 - "CONCLUSIONS: Desonide has a significant therapeutic effect on both the induced conjunctival early- and late-allergic reaction and in active SAC" 07/01/2002 - "PURPOSE: To study the safety and efficacy of the topical corticosteroid, desonide 0.25% ophthalmic solution, for inhibition of the clinical allergic reaction induced by conjunctival provocation (CPT) and for the treatment of seasonal allergic conjunctivitis (SAC)" 09/01/1978 - "Phenylbutazone, cyclophosphamide and prednacinolone acetonide, administered around the period of challenge reduced the exudate of pleurisy due to Bordetella pertussis hypersensitivity in the rat" 09/01/1978 - "Action of phenylbutazone, cyclophosphamide and prednacinolone on pleurisy due to Bordetella pertussis hypersensitivity in the rat." 01/01/1984 - "The actions of F 1865 (ethyl 4' methoxy 4 phenyl thiazolyl 2 oxamate), an inhibitor of the release of histamine from mast cell, desonide, a corticosteroid, mepyramine maleate, an anti-H1 antihistaminic, and disodium cromoglycate were compared after cutaneous application in various experimental models of allergy and inflammation" Get all the results and reference details, order at left...
4.	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 07/01/2002 - "Efficacy and safety of desonide phosphate for the treatment of allergic conjunctivitis." 07/01/2002 - "PURPOSE: To study the safety and efficacy of the topical corticosteroid, desonide 0.25% ophthalmic solution, for inhibition of the clinical allergic reaction induced by conjunctival provocation (CPT) and for the treatment of seasonal allergic conjunctivitis (SAC)" 10/01/2004 - "RECENT FINDINGS: Research developments in ocular allergy summarized in this article include the following findings: (1) ocular epithelial cells play a role in inflammation; (2) respiratory syncytial virus is a pathogen in allergic conjunctivitis; (3) transglutaminase inhibitors reverse allergic related inflammation; (4) eosinophils and neutrophils both play a role in ocular allergy; (5) eotaxin-1 and eotaxin-2 play a role in eosinophilic recruitment; and (6) loteprednol etabonate, desonide phosphate, and cyclosporine have been shown to be effective and safe in the treatment of ocular allergy" Get all the results and reference details, order at left...
5.	Pruritus (Itching) 07/01/2002 - "RESULTS: For the CPT study: individual itching and redness, and the sum score for signs and symptoms were all statistically (p < 0.05) and clinically (greater than 1 change between treated eyes) significantly lower in desonide versus placebo eyes" 07/01/2002 - "Seasonal study: desonide and fluorometholone were both highly effective in reducing itching, tearing, and conjunctival hyperemia over time (p < 0.0001)" Get all the results and reference details, order at left...
20 Diseases and 31 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Hydrocortisone (Cortisol)
2.	Cosmetics
3.	Fluorometholone (FML)
4.	hydrocortisone-17-butyrate (Locoid)
5.	Hydrogel
6.	Chemokine CCL24
7.	Chemokine CCL11
8.	Cyclosporine (Ciclosporin)
9.	loteprednol etabonate (loteprednol)
10.	Desonide (Desowen)
41 Drugs and Important Bio-Agents and 25 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Aftercare (After-Treatment)
1 Therapies and Procedures and 1 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>